Page last updated: 2024-08-26

nsc-172755 and clarithromycin

nsc-172755 has been researched along with clarithromycin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Affolabi, D; Anagonou, SY; Asiedu, K; Barogui, YT; Dossou, AD; Johnson, CR; Portaels, F; Sopoh, GE; Zohoun, T1
Adeye, A; Ardant, MF; Chauty, A; Cottin, J; Goundoté, A; Ji, B; Ladikpo, T; Landier, J; Marsollier, L; Pluschke, G; Ruf, T1
Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T1
Addo, J; Anagonou, ES; Ayelo, AG; Biswas, N; Calderon, F; Cruz, I; Della Pasqua, O; Díez, G; Gine-March, A; Gnimavo, RS; Herrador, Z; Houezo, JG; Johnson, RC; Kpoton, GG; Mendoza-Losana, A; Mignanwande, FZ; Orford, L; Ramón-García, S; Sáez-López, E; Sopoh, GE; Vlasakakis, G1

Trials

2 trial(s) available for nsc-172755 and clarithromycin

ArticleYear
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult

2020
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled mu
    Trials, 2022, Jul-08, Volume: 23, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benin; Buruli Ulcer; Clarithromycin; Clinical Trials, Phase II as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome

2022

Other Studies

2 other study(ies) available for nsc-172755 and clarithromycin

ArticleYear
Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
    The Medical journal of Australia, 2008, Nov-03, Volume: 189, Issue:9

    Topics: Adult; Antibiotics, Antitubercular; Benin; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Skin Transplantation

2008
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jan-01, Volume: 52, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Pilot Projects; Rifampin; Treatment Outcome; Young Adult

2011